Standard BioTools (NASDAQ: LAB)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-07 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.330 | ||||||
REV | 26.500M | 18.777M | -7.723M |
You can purchase shares of Standard BioTools (NASDAQ: LAB) through any online brokerage.
Other companies in Standard BioTools’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codex DNA (NASDAQ:DNAY), Personalis (NASDAQ:PSNL), IsoPlexis (NASDAQ:ISO) and Quoin Pharmaceuticals (NASDAQ:QNRX).
There is no analysis for Standard BioTools
The stock price for Standard BioTools (NASDAQ: LAB) is $1.7 last updated Today at August 10, 2022, 8:00 PM UTC.
There are no upcoming dividends for Standard BioTools.
Standard BioTools’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Standard BioTools.
Standard BioTools is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.